SRE vs ZBIO · P/E 31, rev $13.70B vs rev $10.0M
Sempra Energy (SRE) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
Sempra Energy (SRE) is a utilities - diversified company listed on US.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported SRE revenue for 2025-12-31 was $13.70B. Net income was $1.84B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
SRE currently screens at market cap $59.76B and trailing P/E 31.1. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the SRE and ZBIO stock pages for the full models.
Not investment advice.